New Campath Concentration May Create Both Convenience And Confusion
This article was originally published in The Pink Sheet Daily
Executive Summary
Genzyme/Schering AG's Campath will switch to 30 mg/mL single dose vials that do not require filtering. The Institute for Safe Medication Practices urges caution at hospitals making the switch from the 10 mg/mL ampoules and recommends use of single vial packs to prevent errors.